Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 21, 2026

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

16.1K

How Chimeric Antigen Receptor Design Affects Adoptive T Cell Therapy.

Albert T Gacerez1, Benjamine Arellano1, Charles L Sentman1

  • 1Department of Microbiology and Immunology, Center for Synthetic Immunity, The Geisel School of Medicine at Dartmouth, One Medical Center Drive, Lebanon, New Hampshire.

Journal of Cellular Physiology
|May 11, 2016
PubMed
Summary

Chimeric antigen receptor (CAR) T cell therapy shows promise for treating cancers by targeting specific antigens. This review details CAR construction, design elements, and engineering strategies to enhance T cell function and efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

5xFAD-NSG mice: a preclinical Alzheimer model for human cell therapy studies.

bioRxiv : the preprint server for biology·2026
Same author

Human CAR Tregs Targeting SOD1 and Expressing BDNF Reduce Inflammation and Delay Disease in G93A hSOD1-NSG Mice.

Cells·2025
Same author

Human CD4+CD25+ T cells expressing a chimeric antigen receptor against aberrant superoxide dismutase 1 trigger antigen-specific immunomodulation.

Cytotherapy·2023
Same author

Multifunctional mRNA-Based CAR T Cells Display Promising Antitumor Activity Against Glioblastoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2022
Same author

Superkine IL-2 and IL-33 Armored CAR T Cells Reshape the Tumor Microenvironment and Reduce Growth of Multiple Solid Tumors.

Cancer immunology research·2022
Same author

Engineering a natural ligand-based CAR: directed evolution of the stress-receptor NKp30.

Cancer immunology, immunotherapy : CII·2021

Area of Science:

  • Immunology
  • Biotechnology
  • Cancer Therapy

Background:

  • Chimeric antigen receptor (CAR) T cells are engineered immune cells for cancer treatment.
  • CAR T cells have demonstrated significant success, particularly against B cell malignancies.
  • CARs leverage modular designs to target cell surface antigens and activate T cell functions.

Purpose of the Study:

  • To provide an overview of CAR construction and common designs.
  • To discuss the functional importance of individual CAR regions.
  • To explore engineering strategies for regulating CAR T cell activity.

Main Methods:

  • Review of existing literature on CAR T cell technology.
  • Analysis of CAR design principles and their impact on efficacy.

More Related Videos

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.9K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.5K

Related Experiment Videos

Last Updated: Mar 21, 2026

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

16.1K
Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.9K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.5K
  • Discussion of engineering approaches to modulate CAR T cell function.

    • Main Results:

    • CAR efficacy is influenced by its specific structural components and design.
    • Various engineering strategies can be employed to control CAR T cell activity.
    • Modular CAR designs allow targeting of diverse cell surface antigens.

    Conclusions:

    • Understanding CAR construction is crucial for optimizing T cell-based cancer therapies.
    • Strategic engineering of CARs can enhance their therapeutic potential and safety.
    • CAR T cell therapy represents a rapidly advancing field in oncology.